Ingalls & Snyder LLC’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-10,918
Closed -$441K 433
2016
Q1
$441K Hold
10,918
0.03% 241
2015
Q4
$392K Buy
10,918
+468
+4% +$16.9K 0.03% 254
2015
Q3
$333K Buy
10,450
+247
+2% +$8.41K 0.02% 267
2015
Q2
$346K Sell
10,203
-268
-3% -$9.03K 0.02% 273
2015
Q1
$354K Sell
10,471
-2,737
-21% -$95.3K 0.02% 265
2014
Q4
$463K Hold
13,208
0.03% 243
2014
Q3
$432K Buy
13,208
+2,556
+24% +$87K 0.02% 253
2014
Q2
$361K Hold
10,652
0.02% 274
2014
Q1
$373K Sell
10,652
-85
-0.8% -$3K 0.02% 264
2013
Q4
$392K Hold
10,737
0.02% 244
2013
Q3
$371K Buy
10,737
+263
+3% +$9.2K 0.02% 251
2013
Q2
$354K Buy
+10,474
New +$348K 0.02% 260

Other funds holding ACH

Ingalls & Snyder LLC's ACH Position: Q2 2016 in Review

Ingalls & Snyder LLC sold out of Accendra Health (ACH) in Q2 2016, closing a stake of 10,918 shares — an estimated $441K sold.

Ingalls & Snyder LLC first reported a position in ACH in Q2 2013 and held it in 12 quarters. The position peaked at $463K in Q4 2014. 283 funds tracked by Wall St. Rank hold ACH as of Q2 2016.

  • Ingalls & Snyder LLC reported no remaining Accendra Health position as of Q2 2016 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 10,918 Accendra Health shares in Q2 2016, an estimated $441K.
  • Ingalls & Snyder LLC first reported a position in Accendra Health in Q2 2013 and held it in 12 quarters.
  • Ingalls & Snyder LLC's Accendra Health position peaked at $463K in Q4 2014.
  • 283 funds tracked by Wall St. Rank held Accendra Health as of Q2 2016.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2016, filed 11 Aug 2016.